Bumper returns predicted for 2021
Brexit and Covid-19 among major tailwinds for sector
UK Mid Cap and UK Opps funds affected
Too early to crystallise losses
Global Income fund overweight in mega-cap US stocks
Property and tech expected to boom
When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.
One year on from MiFID II
Slight recovery in investor confidence
Out of over 7,000 firms
Male CEOs earn up to 110% more than females
Bias towards income payers
'Style of the fund has changed dramatically'
Third anniversary this month
Bought into banks for first time since 2003
2016 saw several blow-ups for large drug companies
As the Evenlode Income fund celebrates its seventh anniversary, fund manager Hugh Yarrow highlights the best performing stocks from its portfolio.
Best ideas from host countries since 1980
Focus on high-quality companies
The Merchants trust's Simon Gergel explains why investing in one of the UK's biggest healthcare stocks - GlaxoSmithKline - is not as simple as many investors envisage
Appeal of non-traditional financials
Still positive on prospects
Concerns over sector M&A